(XEN) iShares Jantzi Social Index - Ratings and Ratios
Canadian, Equity, Socially Responsible, Index
Description: XEN iShares Jantzi Social Index
The iShares Jantzi Social Index ETF (TO:XEN) is designed to deliver long-term capital appreciation by tracking the Jantzi Social Index, a benchmark that measures the performance of Canadian companies that pass certain environmental, social, and governance (ESG) criteria. As a Canadian Equity ETF, XEN primarily invests in Canadian equity securities that align with these ESG standards, providing investors with a socially responsible investment option.
By replicating the Jantzi Social Index, XEN offers exposure to a diversified portfolio of Canadian companies that have been vetted for their ESG practices. This index is a widely recognized benchmark for socially responsible investing in Canada, and XENs tracking performance is a key factor in its ability to meet its investment objective. With BlackRock as its issuer, XEN benefits from the firms expertise in ETF management and its commitment to providing investors with transparent and cost-effective investment solutions.
Analyzing the technical data, we observe that XENs last price is $38.81, with its 20-day SMA at $37.30, 50-day SMA at $37.00, and 200-day SMA at $36.29. The ATR indicates a relatively low volatility, with a 1.55% average true range. Given the current price proximity to its 52-week high of $38.84, we can infer that XEN has demonstrated resilience in the recent market. Using the SMAs as a gauge for trend and momentum, we see a positive trend, as the short-term SMAs are above the long-term SMA, suggesting a potential continuation of the upward trend.
Combining the technical analysis with fundamental data, such as the AUM of $129.60M CAD, we can infer that XEN has a reasonable scale to be considered for investment. With a solid track record and a clear investment mandate, XEN is well-positioned to continue attracting investors seeking ESG-aligned investment options. Based on the current technical and fundamental analysis, a forecast for XEN is that it may continue to trend upwards, potentially reaching $40.00 in the near term, driven by its alignment with the Jantzi Social Index and the overall positive trend in the Canadian equity market.
XEN ETF Overview
| Market Cap in USD | 102m |
| Category | Canadian Equity |
| IPO / Inception | 2007-05-14 |
XEN ETF Ratings
| Growth Rating | 85.4 |
| Fundamental | - |
| Dividend Rating | 40.1 |
| Rel. Strength | 6.27 |
| Analysts | - |
| Fair Price Momentum | 45.26 CAD |
| Fair Price DCF | - |
XEN Dividends
| Dividend Yield 12m | 2.16% |
| Yield on Cost 5y | 4.15% |
| Annual Growth 5y | -1.98% |
| Payout Consistency | 94.6% |
| Payout Ratio | % |
XEN Growth Ratios
| Growth Correlation 3m | 98.5% |
| Growth Correlation 12m | 85.6% |
| Growth Correlation 5y | 93% |
| CAGR 5y | 15.54% |
| CAGR/Max DD 5y | 0.87 |
| Sharpe Ratio 12m | 1.93 |
| Alpha | 13.67 |
| Beta | 0.616 |
| Volatility | 11.19% |
| Current Volume | 0.6k |
| Average Volume 20d | 1.4k |
| Stop Loss | 41.3 (-3.2%) |
What is the price of XEN shares?
As of August 13, 2025, the stock is trading at CAD 42.66 with a total of 571 shares traded.Over the past week, the price has changed by +1.62%, over one month by +3.54%, over three months by +11.37% and over the past year by +29.77%.
Is iShares Jantzi Social Index a good stock to buy?
Yes. Based on ValueRay's Analyses, iShares Jantzi Social Index (TO:XEN) is currently (August 2025) a good stock to buy. It has a ValueRay Growth Rating of 85.38 and therefor a clear technical positive rating according to historical growth.Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XEN is around 45.26 CAD . This means that XEN is currently overvalued and has a potential downside of 6.09%.
Is XEN a buy, sell or hold?
iShares Jantzi Social Index has no consensus analysts rating.What are the forecasts/targets for the XEN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 50.4 | 18.1% |
XEN Fundamental Data Overview
Market Cap CAD = 139.8m (139.8m CAD * 1.0 CAD.CAD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 CAD
Beta = 1.05
Revenue TTM = 0.0 CAD
EBIT TTM = 0.0 CAD
EBITDA TTM = 0.0 CAD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 139.8m CAD (139.8m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 139.8m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 139.8m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT none, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(139.8m)/V(0.0) * Re(8.28%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(none)))
Discount Rate = 8.28% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)